原发性硬化性胆管炎患者报告结局:澳大利亚视角
该多中心前瞻性队列研究于2019年12月至2023年8月在澳大利亚纳入55例成人原发性硬化性胆管炎(PSC)患者,完成经验证的PSC患者报告结局(PRO)问卷及合并炎症性肠病(IBD)者的短IBD问卷(SIBDQ)。结果显示除PSC症状外,所有健康相关生活质量(HRQOL)域评分均与肝病严重程度显著相关,失代偿期肝硬化和胆管炎病史与多个HRQOL域降低相关。
要点
- 除PSC症状外,所有HRQOL域评分均与肝病严重程度显著相关。
- 失代偿期肝硬化和胆管炎病史与多个HRQOL域降低相关。
- 较年长对情绪困扰具有保护作用(p=0.01)。
核心结论
- 这是首个在特征明确的前瞻性队列中描述PSC和IBD患者报告结局的澳大利亚研究。
- PSC相关患者报告结局与肝病严重程度显著相关。
- 需要进一步大规模研究来深入探究这些发现。
研究设计与样本
- 多中心、前瞻性队列研究,于2019年12月至2023年8月在澳大利亚纳入成人PSC患者。
- 连续患者完成基线经验证的PSC患者报告结局问卷,合并IBD者完成短IBD问卷(SIBDQ)。
- 采用线性回归探索与不良HRQOL相关的因素及各HRQOL域与肝病严重程度的关系。
- 共纳入55例PSC患者。
主要发现
- 大多数患者为男性(32/55,58%),中位年龄44岁,自PSC诊断中位随访7年。
- 精神和躯体疲劳是最突出的PSC症状。
- 除PSC症状外,所有HRQOL域评分均与肝病严重程度显著相关。
- 失代偿期肝硬化和胆管炎病史与多个HRQOL域降低相关,而较年长对情绪困扰具有保护作用(p=0.01)。
- IBD肠道症状和情绪影响与同一患者的PSC症状和情绪影响呈正相关。
局限性
- 需要进一步大规模研究来深入探究这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Primary sclerosing cholangitis (PSC) is a rare, cholestatic liver condition that has a significant association with inflammatory bowel disease (IBD) and impaired health-related quality of life (HRQOL). We aimed to characterise and compare validated PSC and IBD patient-reported outcomes (PRO) and determine if PRO correlated with the severity of liver disease. METHODS: We conducted a multicentre, prospective cohort study in Australia enrolling adult patients with PSC from December 2019 to August 2023. Consecutive patients completed a baseline validated PSC PRO questionnaire and a short IBD questionnaire (SIBDQ) if they had concomitant IBD. Linear regression was used to explore factors associated with poor HRQOL and the association between each HRQOL domain and the severity of liver disease. RESULTS: A total of 55 PSC patients were included. Most patients were male (32/55, 58%) with a median age of 44 years and a median 7 years of follow-up from PSC diagnosis. Mental and physical fatigue were the most prominent PSC symptoms. All HRQOL domain scores except PSC symptoms were significantly associated with liver disease severity. Decompensated cirrhosis and a history of cholangitis were associated with reduced HRQOL in various domains, whereas older age was protective against emotional distress (p = 0.01). IBD bowel symptoms and emotional impact had a positive correlation with PSC symptoms and emotional impact within the same patient. CONCLUSION: This is the first Australian study describing PSC and IBD PRO in a well-characterised prospective cohort. We have demonstrated that PSC-related PRO is significantly associated with liver disease severity. Further large-scale studies are required to further interrogate these findings.
引用
- Tan N, Zampogna C, Lynch K, et al. Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective. Aliment Pharmacol Ther. 2025. PMID: 40025830. doi:10.1111/apt.70054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。